Bohai Pharmaceutical (BOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2014 | 06-2013 | 06-2012 | 06-2011 | 06-2010 | |
| Sales | 175,086 | 151,793 | 137,373 | 81,329 | 59,265 |
| Cost of Goods | 42,376 | 37,197 | 33,533 | 17,294 | 10,165 |
| Gross Profit | 132,710 | 114,596 | 103,840 | 64,035 | 49,100 |
| Operating Expenses | 100,675 | 87,915 | 76,001 | 46,073 | 36,418 |
| Operating Income | 32,411 | 26,878 | 28,372 | 18,256 | 12,847 |
| Interest Expense | 2,287 | 1,968 | 11,194 | 4,098 | 1,437 |
| Other Income | 1,431 | 1,233 | -214 | 4,612 | 1,052 |
| Pre-tax Income | 31,555 | 26,144 | 16,963 | 18,770 | 12,462 |
| Income Tax | 9,666 | 7,020 | 7,315 | 4,765 | 3,405 |
| Net Income Continuous | 21,889 | 19,124 | 9,648 | 14,005 | 9,057 |
| Net Income | $21,889 | $19,124 | $9,648 | $14,005 | $9,057 |
| EPS Basic Total Ops | 1.22 | 1.07 | 0.54 | 0.81 | 0.62 |
| EPS Basic Continuous Ops | 1.22 | 1.07 | 0.54 | 0.81 | 0.62 |
| EPS Diluted Total Ops | 1.02 | 0.91 | 0.54 | 0.75 | 0.55 |
| EPS Diluted Continuous Ops | 1.00 | 0.87 | 0.42 | 0.62 | 0.52 |
| EPS Diluted Before Non-Recurring Items | 1.02 | 1.07 | 0.54 | N/A | N/A |
| EBITDA(a) | $37,935 | $32,238 | $33,187 | $19,765 | $13,668 |